Isn't it also the reason why ANP did not need to take a prominent role in the annual conference - just his low-key appearance in just an after-the-event panel ?
And that this time they may really have other things in store ?
Ann: ANP to participate in development of DMD Guidance for FDA, page-6
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.8¢ |
Change
-0.004(4.35%) |
Mkt cap ! $79.33M | |||
| Open | High | Low | Value | Volume |
| 9.1¢ | 9.2¢ | 8.7¢ | $87.86K | 983.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 61583 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.8¢ | 16883 | 1 |
View Market Depth
| Last trade - 15.58pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.8¢ |
Change
-0.004 ( 2.76 %) |
||||
| Open | High | Low | Volume | ||
| 9.1¢ | 9.1¢ | 8.7¢ | 237651 | ||
| Last updated 15.58pm 17/06/2024 ? | |||||
| PER (ASX) Chart |
